• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.16% Nasdaq Up 0.25%

    More On VTUS

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Ventrus Biosciences, Inc. (VTUS)

    -NasdaqCM
    1.45 0.00(0.00%) Jul 11, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.45
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:6.50
    Beta:-0.08
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.85 - 4.69
    Volume:0
    Avg Vol (3m):N/A
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for VTUS at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.19
    Quarterly EPS Est (Mar-15) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):-0.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ventrus Biosciences, Inc., a development-stage specialty pharmaceutical company, focuses on the late-stage development and commercialization of gastrointestinal products in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback